Hearing loss is unlikely to be a common symptom of Covid-19, a study led by The University of Manchester and the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) scientists have shown.
Parents of the one in a 1000 newborn babies identified with hearing loss, might soon be able to have the reassurance that their babies are hearing speech through their hearing aids, thanks to a new test.
Manchester BRC researchers presented their latest hearing health research at international conferences in Australia and Birmingham this month.
A world-first genetic test developed by Manchester BRC researchers to establish if a newborn baby is vulnerable to deafness if treated with a commonly used antibiotic, has been conditionally recommended by the National Institute for Health and Care Excellence (NICE) for use within the NHS.
A research team led by Professor Kevin Munro, Manchester BRC Hearing Health Theme Lead, have highlighted the difficulties people face with impacted ear wax, as more and more people face the prospect of ear wax removal services being discontinued at their GP surgeries.
New research supported by Manchester BRC has found that noisy environments can be distracting and pose listening difficulties for autistic people, affecting their social life, emotional wellbeing and career.
People in the UK living with hearing loss and tinnitus could benefit from the first ever national research action plan, in development by three National Institute for Health and Care Research (NIHR) Biomedical Research Centres on behalf of the Department of Health and Social Care and NHS England.
The deputy lead for the Optimising Outcomes programme in the Hearing Health theme for NIHR Manchester Biomedical Research Centre has been recognised as one of the UK’s most influential disabled people.